These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Low-dose methylprednisolone pulse therapy in Chinese children with steroid resistant focal segmental glomerulosclerosis. Chang JW, Yang LY, Wang HH. Pediatr Int; 2007 Jun; 49(3):349-54. PubMed ID: 17532834 [Abstract] [Full Text] [Related]
43. [A case of collapsing variant of FSGS]. Nagai C, Yokota S, Kido Y, Katayama N, Nishiya M, Koizumi H, Namiki M, Nakamoto Y. Nihon Jinzo Gakkai Shi; 2000 Feb; 42(2):47-52. PubMed ID: 10771575 [Abstract] [Full Text] [Related]
44. Other immunosuppressive agents for focal segmental glomerulosclerosis. Ponticelli C, Passerini P. Semin Nephrol; 2003 Mar; 23(2):242-8. PubMed ID: 12704585 [Abstract] [Full Text] [Related]
45. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. Raafat RH, Kalia A, Travis LB, Diven SC. Am J Kidney Dis; 2004 Jul; 44(1):50-6. PubMed ID: 15211437 [Abstract] [Full Text] [Related]
46. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature. Kisner T, Burst V, Teschner S, Benzing T, Kurschat CE. Nephron Clin Pract; 2012 Jul; 120(2):c79-85. PubMed ID: 22286071 [Abstract] [Full Text] [Related]
47. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ. J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302 [Abstract] [Full Text] [Related]
49. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. Lieberman KV, Tejani A. J Am Soc Nephrol; 1996 Jan; 7(1):56-63. PubMed ID: 8808110 [Abstract] [Full Text] [Related]
50. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Hristea D, Hadaya K, Marangon N, Buhler L, Villard J, Morel P, Martin PY. Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660 [Abstract] [Full Text] [Related]
51. Repeated Administrations of Rituximab along with Steroids and Immunosuppressive Agents in Refractory Steroid-resistant Nephrotic Syndrome. Fujinaga S, Sakuraya K. Indian Pediatr; 2017 Jan 15; 54(1):49-50. PubMed ID: 28141565 [Abstract] [Full Text] [Related]
52. [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis]. Passerini P, Scolari F, Frasca' GM, Leoni A, Venturelli C, Dallera N, Ravera S, Balestra E, Freddi P, Fanciulli E, D'Arezzo M, Sagripanti S. G Ital Nefrol; 2009 Jan 15; 26(5):563-76. PubMed ID: 19802802 [Abstract] [Full Text] [Related]
53. Focal segmental glomerulosclerosis and nephrotic syndrome in a child with embryonal rhabdomyosarcoma. Olowu WA, Salako AA, Adelusola KA, Sowande OA, Adetiloye VA, Adefehinti O, Osasan SA. Clin Exp Nephrol; 2008 Apr 15; 12(2):144-148. PubMed ID: 18175060 [Abstract] [Full Text] [Related]
54. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Braun N, Schmutzler F, Lange C, Perna A, Remuzzi G, Risler T, Willis NS. Cochrane Database Syst Rev; 2008 Jul 16; 2008(3):CD003233. PubMed ID: 18646090 [Abstract] [Full Text] [Related]
55. Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response. Arbus GS, Poucell S, Bacheyie GS, Baumal R. J Pediatr; 1982 Jul 16; 101(1):40-5. PubMed ID: 7045316 [Abstract] [Full Text] [Related]
56. T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS. Chan CY, Liu ID, Resontoc LP, Ng KH, Chan YH, Lau PY, Than M, Jordan SC, Lam KP, Yeo WS, Yap HK. Clin J Am Soc Nephrol; 2016 Aug 08; 11(8):1360-1368. PubMed ID: 27269610 [Abstract] [Full Text] [Related]
57. Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children. Han KH, Kim SH. Biomed Res Int; 2016 Aug 08; 2016():3053706. PubMed ID: 27195285 [Abstract] [Full Text] [Related]
58. Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome. Tenta M, Uchida HA, Nunoue T, Umebayashi R, Okuyama Y, Kitagawa M, Maeshima Y, Sugiyama H, Wada J. CEN Case Rep; 2015 Nov 08; 4(2):190-195. PubMed ID: 28509096 [Abstract] [Full Text] [Related]
59. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis. Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M. Nephrol Dial Transplant; 2005 Apr 08; 20(4):735-42. PubMed ID: 15772265 [Abstract] [Full Text] [Related]
60. Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis. Shatat IF, Schoeneman M, Flynn JT, Woroniecki RP. Pediatr Nephrol; 2007 Jun 08; 22(6):834-9. PubMed ID: 17294224 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]